Research by Loeske et al. corroborated that pre-activated antiviral 'INNATE' immunity in the upper airways controls early SARS-CoV-2 infection in children; this is the 'FIRST line of defense' in kids
by Paul Alexander
Good & bad news; this innate immunity in children has protected them against a broad range of pathogen; innate antibodies & innate natural killer cells (NK cells) that protects; VACCINE can damage it
KEY message: children must never ever be given these vaccines as they do not need them, they have near zero risk, the vaccines have been shown to carry risks including myocarditis, and children have their own potent innate immune system that is magical and potent.
However, this innate immune system can be damaged by COVID vaccines and I will explain lower down.
First, I wanted to highlight this research by Loeske et al. that corroborated the pre-activated antiviral INNATE immunity in the upper airways that controls early SARS-CoV-2 infection in children; as indicated above, this is the first line of defense and this is potent innate immunity (mucosal layer) and it dispatches and vanquishes pathogen that come at children. It is vicious, potent, non-specific, low-affinity, and at high antibody titres (Geert told me mainly IgMs). It destroys anything and protects children.
The reality is that infants, children, and young persons have a significantly reduced risk of developing coronavirus disease 2019 (COVID-19), this despite a similar risk of infection. This study revealed that the transcriptional environment in the upper airways in children (respiratory tract) had a greater basal expression of relevant pattern recognition receptors such as MDA5 (IFIH1) and RIG-I (DDX58), macrophages and dendritic cells. They reported a consequential more robust and rigorous innate antiviral responses in children relative to adults when exposed and infected with SARS-CoV-2. They reported on “SARS-CoV-2-negative (n = 18) and age-matched SARS-CoV-2-positive (n = 24) children and corresponding samples from adults (n = 44), covering an age range of 4 weeks to 77 years.” Children also revealed distinct immune cell sub-groups that included “KLRC1 (NKG2A)+ cytotoxic T cells and a CD8+ T cell population with a memory phenotype”. This subpopulation occurred principally in children. Loeske et al. concluded that the airway immune cells of children are already pre-activated and primed for viral sensing, and this results in a far more robust and stronger early innate antiviral response to SARS-CoV-2 infection relative to adults.
But I wanted to provide a warning:
There is a strong chance that the vaccinal antibodies can suppress the innate antibodies in children, and can subvert them. There is emerging evidence and Geert has re-iterated this to me. The innate antibodies in children can be ‘outcompeted’ by vaccinal antibodies post COVID vaccine and the real concern is that with boosting, the vaccinal antibodies would be boosted continually which would work to keep the innate antibodies continually suppressed. This can leave children defenseless as to their normally functional potent innate immune defenses. This is our concern.